Clinical Trial Update: [F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating [F-18] RGD-K5 PET imaging in participants with carotid artery stenosis; the trial was terminated and results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Stenosis

Drugs mentioned

• F-18 RGD-K5 (fluorine-18 labeled RGD-K5)

Snippet

Sponsor: Siemens Molecular Imaging | Conditions: Carotid Stenosis | Phase 2 | Status: TERMINATED | Results posted: 2013-09-27